Skip to main content
TipRanks
Go Ultimate75% OFF

Symbio Pharmaceuticals Limited (4582) Q2 2022 Earnings Report

1 Followers

JP:4582 Q2 2022 EPS Results

Actual EPS
JPY 24.46
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
JPY 0.12

JP:4582 Q2 2022 Revenue Results

Actual Revenue
JPY 2.56B
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+48.16%

Earnings Announcement Details

Quarter
Q2 2022
Date
08/04/2022
Time
TBA
Conference Call
Thursday, August 4, 2022
JP:4582 Upcoming Earnings

Symbio Pharmaceuticals Limited's next earnings date is estimated for February 11, 2027, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

JP:4582 Earnings History

JP:4582 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 11, 20272026 (Q4)―--21.66――
Oct 29, 20262026 (Q3)―-15.01-24.1137.76% (+9.10)
Jul 30, 20262026 (Q2)―-15.00-21.429.91% (+6.40)
May 07, 20262026 (Q1)―-35.89-27.95-28.41% (-7.94)
Feb 05, 20262025 (Q4)―-21.66-21.57-0.42% (-0.09)
Oct 30, 20252025 (Q3)―-24.11-28.6815.93% (+4.57)
Jul 31, 20252025 (Q2)―-21.40-16.72-27.99% (-4.68)
May 08, 20252025 (Q1)―-27.95-18.03-55.02% (-9.92)
Feb 06, 20252024 (Q4)―-21.57-47.1754.27% (+25.60)
Oct 31, 20242024 (Q3)―-28.68-17.87-60.49% (-10.81)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed